Claudia Lennicke

Claudia Lennicke

Auto-generated profile, based on publicly available information

Claudia Lennicke

MRC Laboratory of Medical Sciences (LMS) London UK

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 June 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
CLClaudia Lennicke
Claudia Lennicke
IBIvana Bjedov
Ivana Bjedov
SGSebastian Grönke
Sebastian Grönke
KMKatja E. Menger
Katja E. Menger
AJAndrew M. James
Andrew M. James
HCHelena M. Cochemé
Helena M. Cochemé
Dysregulation of redox homeostasis is implicated in the ageing process and the pathology of age-related diseases. To study redox signalling by H2O2 in vivo, we established a redox-shifted model by manipulating levels of the H2O2-degrading enzyme catalase in Drosophila. Here we report that ubiquitous over-expression of catalase robustly extends lifespan in females. As anticipated, these flies are strongly resistant to a range of oxidative stress challenges, but interestingly are sensitive to starvation, which could not be explained by differences in levels of energy reserves. This led us to explore the contribution of autophagy, which is an important mechanism for organismal survival in response to starvation. We show that autophagy is essential for the increased lifespan by catalase upregulation, as the survival benefits are completely abolished upon global autophagy knock-down. Furthermore, using a specific redox-inactive knock-in mutant, we highlight the in vivo role of a key regulatory cysteine residue in Atg4a, which is required for the lifespan extension in our catalase model. Altogether, these findings confirm the redox regulation of autophagy in vivo as an important modulator of longevity.

29 September 2026 in Aging Cell
Verified
Journal Article
Open access
PDF file
ESEliano dos Santos
Eliano dos Santos
MBMarie Blickling
Marie Blickling
FLFiona C. Leiper
Fiona C. Leiper
John-Patrick AlaoJohn-Patrick Alao
John-Patrick Alao
CLClaudia Lennicke
Claudia Lennicke
HCHelena M. Cochemé
Helena M. Cochemé
AMP‐activated protein kinase (AMPK) is a key evolutionarily conserved sensor of energy homeostasis and plays a central role in metabolic health and disease. AMPK has also been implicated in ageing; however, most in vivo drug studies rely on the use of indirect activators, such as metformin, which have complex modes‐of‐action, therefore making conclusions on the specific role of AMPK more challenging. Here, we demonstrate that direct activation of AMPK with the compound 991 extends lifespan in Drosophila melanogaster , Caenorhabditis elegans and Schizosaccharomyces pombe . In mice, 991 treatment induces a pro‐longevity proteomic profile, highlighting the potential for translation to mammals. Overall, our study provides important proof‐of‐principle for AMPK as a pharmacological target with longevity benefits.